Genetic Basis of Neutropenia Disorders

Displaying 1 - 10 of 10CSV
Dominy, J., Bai, J., Koch, C., Zaman Khan, M., Khalid, S., Chung, J. H., Panditrao, M., Liu, L., Zhang, Q., Jahanzaib, M., Mian, M. R., Liaqat, M. B., Raza, S. S., Sultana, R., Jalal, A., Saeed, M. H., Abbas, S., Memon, F. R., Ishaq, M., … Saleheen, D. (2025). Human CD33 deficiency is associated with mild alteration of circulating white blood cell counts. PLOS Genetics, 21(3), e1011600. https://doi.org/10.1371/journal.pgen.1011600
Publication Date
Bhutani, D., Chakraborty, R., Wats, K., Hughes, M. S., Dor, L., Sekulic, M., & Lentzsch, S. (2025). Treatment of Refractory Monoclonal Immunoglobulin Deposition Disease With BCMA Bispecific Antibody. European Journal of Haematology. Portico. https://doi.org/10.1111/ejh.14393
Publication Date
Jash, A., Pridmore, T., Collins, J. B., Hay, A. M., Hudson, K. E., Luckey, C. J., & Zimring, J. C. (2024). Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice. Journal of Clinical Investigation, 134(8). https://doi.org/10.1172/jci167665
Publication Date
Kuter, D. J., Cataland, S. R., Broome, C. M., & Neunert, C. (2024). The latest insights into rare blood disorders: Diagnosis and treatment strategies. American Journal of Hematology. Portico. https://doi.org/10.1002/ajh.27285
Publication Date
Vander Haar, E., Abshier Ware, C., Allen, G., Armstrong, R., Black, D., Bombara, M., Dhanraj, D., Lawrence, L., Miller, R., Nanda, S., Paidas, M. J., Patki, K. C., Sitras, V., Skupski, D., Swarup, M., Thorp, J., Tiller, H., Verweij, J., & Bussel, J. B. (2023). Identifying Pregnancies at Higher Risk for HPA-1a Alloimmunization and Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): An International, Prospective, Natural History Study. Blood, 142(Supplement 1), 1224–1224. https://doi.org/10.1182/blood-2023-177657
Publication Date
Fu, J., Li, S., MA, H., Brown, L. M., Mapara, M., & Lentzsch, S. (2023). Checkpoint Inhibitor PD-1H/VISTA Affects Myeloma Bone Disease By Osteoclast Cytoskeleton Remodeling. Blood, 142(Supplement 1), 6610–6610. https://doi.org/10.1182/blood-2023-189820
Publication Date
Hussain, A., Acharya, A., Bharadwaj, T., Genomics, U. O. W. C. F. M., Leal, S. M., Khaliq, A., Mir, A., & Schrauwen, I. (2023). A Novel Variant in VPS13B Underlying Cohen Syndrome. BioMed Research International, 2023(1). Portico. https://doi.org/10.1155/2023/9993801
Publication Date
Mosialou, I., Ali, A. M., Adams, R., Corper, A., Woods, C. M., Fan, X., Raza, A., & Kousteni, S. (2022). Therapeutic Anti-Jagged1 Antibody Targeting Osteoblast-Related Myeloid Dysplasia to Overcome Standard of Care Resistance. Blood, 140(Supplement 1), 2902–2902. https://doi.org/10.1182/blood-2022-167042
Publication Date
Choe, J., Habal, M. V., Restaino, S. W., Latif, F., Clerkin, K. J., Yuzefpolskaya, M., Sayer, G., Uriel, N., & Jennings, D. L. (2022). Managing Contemporary AMR with a 4-Tiered Treatment Protocol: A Single-Center Experience. The Journal of Heart and Lung Transplantation, 41(4), S412. https://doi.org/10.1016/j.healun.2022.01.1036
Publication Date